Lanthanoid Series Elements
- Lanthanoid Series Elements
- Accession Number
Elements of the lanthanoid series including atomic number 57 (LANTHANUM) through atomic number 71 (LUTETIUM).
Drug Drug Description Lanthanum carbonate A phosphate binder indicated for the reduction of serum phosphate in patients with end stage renal disease. Gadolinium Gadolinium is under investigation in Hypertension, ACUTE KIDNEY INJURY, and Chronic Kidney Disease. Gadolinium has been investigated for the basic science of CAD, Multiple Sclerosis, and Coronary Artery Disease. Samarium Samarium has been used in trials studying the treatment and prevention of Pain, Cancer, Metastasis, Prostate Cancer, and Metastatic Osteosarcoma, among others. Neodymium Neodymium is under investigation in clinical trial NCT03525522 (Nd:Yttrium Aluminum Garnet Laser Treatment for Lichen Sclerosus). Gadoteridol A medication used to improve the contrast of MRI scans for better visualization. EP-2104R Investigated for use/treatment in cardiovascular disorders and thrombosis. Gadofosveset trisodium An intravenous contrast agent used during magnetic resonance angiography (MRA) to evaluate aortoiliac occlusive disease (AIOD) in adults with peripheral vascular disease. Samarium Sm-153 A radiopharmaceutical indicated in the treatment of bone pain in patients with skeletal metastases. Lutetium Lu-177 Not Annotated Gadopiclenol A gadolinium-based contrast agent (GBCA) used with magnetic resonance imaging (MRI) to detect and visualize lesions with abnormal vascularity. AGuIX AGuIX is an investigational brand product consisting of a polysiloxane matrix and gadolinium chelates. It is under development as a radiosensitizer to be used during radiation treatment of malignant glioma. Cerium dioxide Not Annotated
- Drugs & Drug Targets
Drug Target Type Lanthanum carbonate Phosphate target EP-2104R Fibrinogen alpha chain target Gadofosveset trisodium Serum albumin carrier